Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation

Clinical trial NCT03443791 · COMPLETED

Trial details

NCT number: NCT03443791
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Cmv Congenital CMV Viremia

Start date: 2022-09-01
Primary completion: 2025-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.